Monday, January 21, 2013

NLT SPINE - Product Pipeline Analysis.

NLT Spine (NLT) is clinical stage pharmaceutical
company. It specializes in the development and marketing of innovative
minimally invasive spinal surgery products for treating degenerative
spinal conditions. It offers prow fusion, a segmented non-linear
structure inserted into the body by means of the conduit; mSPIN
discectomy tool are inserted to the disc area through the conduit;
eSPIN, an electrical tool; and prow spacer, a device for the treatment
of degenerative lumbar spinal canal stenosis. NLT is headquartered in
Kfar Saba, Israel.

The company aims to improve patient care by
shifting from traditional open surgical routines to MISS, employing new
methods and technologies to enhance safety, predictability and outcomes.
Recently, the companys eSPIN powered discectomy system received 510(k)
clearance from the U.S. Food and Drug Administration (FDA).

This
report is a source for data, analysis and actionable intelligence on the
NLT SPINE portfolio of pipeline products. The report provides detailed
analysis on each pipeline product with information on the indication,
the development stage, trial phase, product milestones, pipeline
territory, estimated approval date, and estimated launch date

Each
pipeline product is profiled to cover information on product
description, function, technology, indication, and application. The
report is also supplemented with a detailed company profile and
information on clinical trials, wherever applicable.

Develop competition strategies by identifying the status and likely
launch of your competitors pipeline products through review of the
clinical trials, stage and phase of development, etc.- Which are the
next high-value products that your competitor would add in its
portfolio? identify, understand and capitalize.